Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2008
12/11/2008US20080306002 Combination Therapy for Preventing Angiogenesis
12/11/2008US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
12/11/2008US20080305490 Amplification of human mdm2 gene in human tumors
12/11/2008US20080305188 Composition and method for supporting cancer treatments
12/11/2008US20080305131 Cancer Immunotherapy with Semi-Allogeneic Cells
12/11/2008US20080305125 Mutant Forms Of EtxB and CtxB And Their Use As Carriers
12/11/2008US20080305120 Immunogenic Compositions Comprising Hmgb 1 Polypeptides
12/11/2008US20080305111 Anti-C35 antibodies for treating cancer
12/11/2008US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof
12/11/2008US20080305104 Cytotoxicity mediation of cells evidencing surface expression of TROP-2
12/11/2008US20080305102 Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer
12/11/2008US20080305091 Poly-Epitope Peptide Derived from Thymidylate Synthase Having Immunological and Anti-Tumour Activity
12/11/2008US20080305090 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
12/11/2008US20080305088 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
12/11/2008US20080305082 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof
12/11/2008US20080305081 Novel aminopyrimidine derivatives as PLK1 inhibitors
12/11/2008US20080305080 Recombinant super-compound interferon
12/11/2008US20080305077 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
12/11/2008US20080305075 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs
12/11/2008US20080305074 Stem cell factor
12/11/2008US20080305044 Engineered Antibodies and Immunoconjugates
12/11/2008US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells
12/11/2008DE10322108B4 Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit Antiandrogens pyrrolidines with antitumor efficacy
12/11/2008DE102007026877A1 Verwendung des Fibroblastenwachstumsfaktors 7 (Fgf7) und des Rezeptors Fgfr2b als Biomarker Use of the fibroblast growth factor 7 (FGF7) and the receptor FGFR2b as biomarkers
12/11/2008DE102007026341A1 Benzoxazolonderivate Benzoxazolonderivate
12/11/2008DE102007025717A1 Arylether-pyridazinonderivate Aryl ether pyridazinone derivatives
12/11/2008CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/11/2008CA2689938A1 Compositions and methods for treating pancreatic tumors
12/11/2008CA2689914A1 Methods and compositions for treating recurrent cancer
12/11/2008CA2689554A1 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
12/11/2008CA2689514A1 Heterobicyclic compounds as kinase inhibitors
12/11/2008CA2689242A1 Agent and method for treatment of cancer
12/11/2008CA2687819A1 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label
12/11/2008CA2687274A1 Use of hdac inhibitors for the treatment of bone destruction
12/11/2008CA2687243A1 Piperidine/piperazine derivatives
12/10/2008EP2000545A1 Compositions and methods for the diagnosis and treatment of tumor
12/10/2008EP2000482A1 Compositions and methods for the diagnosis and treatment of tumor
12/10/2008EP2000469A2 Acylaminopiperidine compound
12/10/2008EP2000465A1 Triazolone derivative
12/10/2008EP2000150A2 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
12/10/2008EP2000149A1 Chimeric anti-CD20 antibody
12/10/2008EP2000148A1 Compositions and methods for the diagnosis and treatment of prostate cancer
12/10/2008EP2000140A1 Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5H-imidazolo[3,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer
12/10/2008EP2000139A1 Stabilized amorphous forms of imatinib mesylate
12/10/2008EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/10/2008EP1999151A2 Diagnostics and treatments for tumors
12/10/2008EP1999148A2 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
12/10/2008EP1999139A2 Betulonic acid esters and betulinic acid polyalkylene-glycol derivatives for the treatment of viral infection and cancer
12/10/2008EP1999137A1 Synthetic archaeal glycolipid adjuvants
12/10/2008EP1999136A1 Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use
12/10/2008EP1999135A2 Kinase inhibitors
12/10/2008EP1999131A2 Bicyclo-pyrazoles active as kinase inhibitors
12/10/2008EP1999127A1 Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents
12/10/2008EP1999126A1 Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53
12/10/2008EP1998806A1 Anti-igf-1r human monoclonal antibody formulation
12/10/2008EP1998799A2 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
12/10/2008EP1998760A2 Non peptidic molecules for detecting and treating tumors
12/10/2008EP1804827B1 Methods for treating colon cancer with botulinum neurotoxin
12/10/2008EP1673085A4 C-met modulators and methods of use
12/10/2008EP1660477B1 Novel farnesyl protein transferase inhibitors as antitumor agents
12/10/2008EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/10/2008EP1492501B1 Methods of using lamellar bodies for therapeutic purposes
12/10/2008EP1487410B1 Preparation of sterile stabilized nanodispersions
12/10/2008EP1403284B1 HAb18G/CD147, ITS ANTAGONIST AND APPLICATION
12/10/2008EP1326531A4 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
12/10/2008EP1289549B1 The use of plant oil-bodies in vaccine delivery systems
12/10/2008EP1274450B1 Medical uses of agonsist and antagonists of IL-174
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008EP1042350B1 Inducible phosphofructokinase and the warburg effect
12/10/2008EP1021464B1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
12/10/2008EP1002069B1 Peptides containing the motif igd and their use as cell migration modulators
12/10/2008CN101321861A Method for generating dendritic cells employing decreased temperature
12/10/2008CN101321784A Nanobodies and polypeptides against EGFR and IGF-IR
12/10/2008CN101321769A Process for the preparation of purified crystalline CCI-779
12/10/2008CN101321768A 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
12/10/2008CN101321763A Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors
12/10/2008CN101321762A Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
12/10/2008CN101321760A Pyrazolopyrimidines as protein kinase inhibitors
12/10/2008CN101321759A Pyrazolopyrimidines as protein kinase inhibitors
12/10/2008CN101321757A Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer
12/10/2008CN101321756A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
12/10/2008CN101321751A Met kinase inhibitors
12/10/2008CN101321739A Quinazoline derivatives used as inhibitors of erbB tyrosine kinase
12/10/2008CN101321538A Interleukin-11 compositions and methods of use
12/10/2008CN101321535A Heteroaromatic sulfonamide prodrugs
12/10/2008CN101321532A Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis
12/10/2008CN101321529A Diaryl aether derivant as antineoplastic agent
12/10/2008CN101321528A 3 , llb-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
12/10/2008CN101321527A Method of treating abnormal cell growth
12/10/2008CN101319247A IL-2 selective agonists and antagonists
12/10/2008CN101319215A Human tumour specific Ki67 gene promotor
12/10/2008CN101319201A Method for inducing malignant tumor cell apoptosis and uses thereof
12/10/2008CN101318980A Dicaryon platinum containing complex, preparation method and application thereof
12/10/2008CN101318966A Dimerized sesquiterpenoids, preparation and application thereof
12/10/2008CN101318965A Hairy sepal ponicidin crystallization, preparation method and medicament composition containing the same
12/10/2008CN101318946A Dimeric ainsliaea terpene A, preparation and application thereof
12/10/2008CN101318930A Herbimycin derivant, preparation method and antineoplastic application thereof
12/10/2008CN101318022A Metal-polysaccharide conjugates and synthesis method
12/10/2008CN101318018A Application of anti-aFGF-scFv in preparing antineoplastic medicament and preparation method thereof
12/10/2008CN101318011A Pentapeptide nose spraying agent for thymus gland, preparation method and application thereof
1 ... 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 ... 2211